Willingness, Attitude, and Associated Factors towards Adverse Drug Reaction Reporting among Healthcare Providers in Mizan Tepi University Teaching Hospital, Southwest Ethiopia

Table 5

Attitude of healthcare providers towards ADR reporting in Mizan Tepi University Teaching Hospital from August to September 2021.

Variables	N (%)
	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
ADR reporting is duty of health professionals	115 (60.5)	65 (34.2)	3 (1.6)	5 (2.6)	2 (1.1)
ADRs need to be sure before reporting	79 (41.6)	96 (50.5)	4 (2.1)	10 (5.3)	1 (0.5)
ADR report improves patient’s safety	81 (42.6)	86 (45.3)	11 (5.8)	11 (5.8)	1 (0.5)
All suspected ADRs should be reported	39 (20.5)	56 (29.5)	47 (24.7)	46 (24.2)	2 (1.1)
ADR reporting trends identify relatively safe drugs	45 (23.7)	92 (48.4)	33 (17.4)	17 (8.9)	3 (1.6)
ADR reporting creates workload	21 (11.1)	37 (19.5)	49 (25.8)	72 (37.9)	11 (5.8)
ADR reporting is not important for the healthcare system	12 (6.3)	23 (12.1)	18 (9.5)	82 (43.2)	55 (28.9)
Reporting of ADR affects patient’s confidentiality issues	15 (7.9)	35 (18.4)	31 (16.3)	85 (44.7)	24 (12.6)
A single ADR report brings no difference	10 (5.3)	22 (11.6)	37 (19.5)	93 (48.9)	28 (14.7)
Fear of legal liability affects ADR reporting	32 (16.8)	40 (21.1)	37 (19.5)	66 (34.7)	15 (7.9)